Hill-Rom Inc – FDA Warning Letter, Oct 11, 2011

On March 2, 2012, the FDA issued a Warning Letter to Hill-Rom, Inc. following an inspection from September 20 to October 11, 2011, at their Batesville, Indiana facility. The inspection found that the firm's AC-Powered Patient Lifts and AC-Powered Adjustable Hospital Beds were adulterated under 21 U.S.C. § 351(h) because their manufacturing, packing, storage, or installation methods did not conform to the Quality System (QS) regulation (21 CFR Part 820).

Key violations included: 1. **Design Verification (21 CFR 820.30(f)):** Failure to adequately verify device design, with design verification activities not confirming design output met input requirements, incomplete traceability summaries, and inadequate objective evidence for design requirement specifications. 2. **Corrective and Preventive Actions (CAPA) (21 CFR 820.100(a)):** Inadequate CAPA system, exemplified by 336 VersaCare bed battery failures without investigation or corrective action, and improper trending of discontinued components. 3. **Process Validation (21 CFR 820.75(a)):** Failure to fully validate automated/semi-automated processes for VersaCare beds, with an inadequate validation procedure only allowing periodic monitoring instead of full validation. 4